Vanguard Portfolio Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.71B Buy
19,791,156
+134,616
+0.7% +$11.2M 0.08% 282
2026
Q2
$1.32B Buy
19,656,540
+436,587
+2% +$29.1M 0.06% 366
2026
Q1
$1.21B Buy
+19,219,953
New +$1.34B 0.06% 361

Other funds holding DXCM

Vanguard Portfolio Management's DXCM Position: Q3 2026 in Review

Vanguard Portfolio Management increased its DexCom (DXCM) stake by 0.68% in Q3 2026, buying an estimated $11.2M and bringing the position to 19,791,156 shares worth $1.71B. The position accounts for 0.08% of the portfolio, ranked #282.

Vanguard Portfolio Management first reported a position in DXCM in Q1 2026 and has held it in 3 quarters since. 937 funds tracked by Wall St. Rank hold DXCM as of Q3 2026.

  • Vanguard Portfolio Management held 19,791,156 shares of DexCom worth $1.71B as of Q3 2026.
  • Vanguard Portfolio Management bought 134,616 DexCom shares in Q3 2026, an estimated $11.2M.
  • DexCom made up 0.08% of Vanguard Portfolio Management's portfolio in Q3 2026, its #282 holding.
  • Vanguard Portfolio Management first reported a position in DexCom in Q1 2026 and has held it in 3 quarters since.
  • 937 funds tracked by Wall St. Rank held DexCom as of Q3 2026.

Based on Vanguard Portfolio Management's 13F filing for Q3 2026, filed 13 Nov 2026.